| 1 |
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al. · Nature Chemical Biology
|
27 Apr 2015 |
561 |
| 2 |
The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
Karsten Ruscher, Mehrdad Shamloo, Mattias Rickhag et al. · Brain
Open access |
27 Jan 2011 |
177 |
| 3 |
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase
Anil K. Padyana, Stefan Größ, Lei Jin et al. · Nature Communications
Open access |
3 Jan 2019 |
164 |
| 4 |
Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2
Rosalyn R. Ram, Gustavo Lorente, Karoly Nikolich et al. · Journal of Neuro-Oncology
|
16 Sep 2005 |
124 |
| 5 |
Facile synthesis of chitin nanocrystals decorated on 3D cellulose aerogels as a new multi-functional material for waste water treatment with enhanced anti-bacterial and anti-oxidant properties
Sreerag Gopi, Preetha Balakrishnan, Chandradhara Divya et al. · New Journal of Chemistry
|
2017 |
61 |
| 6 |
Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results
Anita L. Nelson, Andrew M. Kaunitz, Robin Kroll et al. · Contraception
Open access |
28 Nov 2020 |
32 |
| 7 |
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives
Jeanne E. Loughlin, John D. Seeger, Patricia Mona Eng et al. · Contraception
|
13 Aug 2008 |
30 |
| 8 |
Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies
Vishal Sachdeva, Yun Bai, Agis F. Kydonieus et al. · International Journal of Pharmaceutics
|
20 Dec 2012 |
30 |
| 9 |
Ethinyl estradiol and levonorgestrel pharmacokinetics with a low-dose transdermal contraceptive delivery system, AG200-15: a randomized controlled trial
David F. Archer, Frank Z. Stanczyk, Arkady Rubin et al. · Contraception
|
8 Dec 2011 |
29 |
| 10 |
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
Samuel Harold Sigal, Alpesh Amin, Joseph Chiodo et al. · Canadian Journal of Gastroenterology and Hepatology
Open access |
27 Sep 2018 |
26 |
| 11 |
Safety and tolerability of a new low-dose contraceptive patch in obese and nonobese women
Andrew M. Kaunitz, David F. Archer, Daniel R. Mishell et al. · American Journal of Obstetrics and Gynecology
|
16 Sep 2014 |
20 |
| 12 |
Pharmacokinetics and adhesion of the Agile transdermal contraceptive patch (AG200-15) during daily exposure to external conditions of heat, humidity and exercise
David F. Archer, Frank Z. Stanczyk, Arkady Rubin et al. · Contraception
|
15 Nov 2012 |
19 |
| 13 |
OSWG Recommended Approaches to the Nonclinical Pharmacokinetic (ADME) Characterization of Therapeutic Oligonucleotides
Cindy L. Berman, Madeleine Antonsson, Sándor Bátkai et al. · Nucleic Acid Therapeutics
Open access |
17 Aug 2023 |
17 |
| 14 |
No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
Hwa-ping Feng, Zifang Guo, Luzelena Caro et al. · Clinical and Translational Science
Open access |
24 Jul 2018 |
14 |
| 15 |
Ovarian activity in obese and nonobese women treated with three transdermal contraceptive patches delivering three different doses of ethinyl estradiol and levonorgestrel
Marie L. Foegh, David F. Archer, Frank Z. Stanczyk et al. · Contraception
|
Oct 2012 |
13 |
| 16 |
Pharmacokinetics, tolerability and cycle control of three transdermal contraceptive delivery systems containing different doses of ethinylestradiol and levonorgestrel
Frank Z. Stanczyk, Arkady Rubin, Lisa Flood et al. · Hormone Molecular Biology and Clinical Investigation
|
7 Mar 2011 |
13 |
| 17 |
The emerging role of obesity in short-acting hormonal contraceptive effectiveness
Alison B. Edelman, James Trussell, Abigail R.A. Aiken et al. · Contraception
Open access |
18 Dec 2017 |
12 |
| 18 |
Therapeutically equivalent pharmacokinetic profile across three application sites for AG200-15, a novel low-estrogen dose contraceptive patch
Frank Z. Stanczyk, David F. Archer, Arkady Rubin et al. · Contraception
|
8 Dec 2012 |
8 |
| 19 |
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model
Frank Z. Stanczyk, David F. Archer, Lauren R. L. Lohmer et al. · PLoS ONE
Open access |
27 Dec 2022 |
4 |
| 20 |
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants
Keith E. Boundy, Yang Liu, Pratik R. Bhagunde et al. · Clinical Pharmacology in Drug Development
|
25 Mar 2020 |
4 |
| 21 |
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial
Michal Geva, Y. Paul Goldberg, Melanie L. Leitner et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Open access |
17 Dec 2025 |
3 |
| 22 |
Pridopidine treatment benefits in definite, probable, and early (<18mo onset) subjects with ALS in the HEALEY ALS Platform Trial
Michal Geva, Y. Paul Goldberg, Melanie L. Leitner et al. · Neurotherapeutics
Open access |
Jul 2025 |
1 |
| 23 |
Adhesion Evaluation of AG200-15: An Investigational Transdermal Contraceptive Delivery System
Terrance Ocheltree, Janet Wittes, Jessica Case et al. · Advances in Therapy
|
10 Oct 2019 |
1 |
| 24 |
Complications of NSAIDs for patients over age 65.
G E Farrar · PubMed
|
8 Mar 1990 |
1 |
| 25 |
An Automated Listener-Effort Measure for ALS Generalizes across Diverse Platforms and Protocols
Esteban G. Roitberg et al. · Research Square
PreprintOpen access |
14 Jul 2026 |
0 |
| 26 |
In the phase 3 PROOF-HD trial, pridopidine shows consistent motor function improvements in Q-Motor measures, supporting Q-Motor as a predictive measure of long-term functional benefit and slower progression (cUHDRS) in Huntington disease
Michal Geva, Ralf Reilmann, Robin Schubert et al. · Neurotherapeutics
Open access |
Jul 2025 |
0 |
| 27 |
Supplementation of Griffonia simplicifolia and a Mushroom Blend Positively Influence Mood and Sleep Quality in Young Adults
Melissa Riddell, Rachel Nye Venter, REC Wildman et al. · Current Developments in Nutrition
Open access |
May 2025 |
0 |
| 28 |
IMPACT OF APPLICATION SITE AND BODY MASS INDEX ON ADHESION AND TOLERABILITY OF A LEVONORGESTREL/ETHINYL ESTRADIOL TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM
Andrew M. Kaunitz, Anita L. Nelson, Kurt Thomas Barnhart et al. · Fertility and Sterility
Open access |
Sep 2021 |
0 |
| 29 |
High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study
PM Meyer, ID Grachev, GA Becker et al. · Nuklearmedizin - NuclearMedicine
Conference paper |
Apr 2020 |
0 |
| 30 |
Safety and side effects with investigational contraceptive patch use in women with and without hormonal contraceptive experience
Paula M. Castaño, James A. Simon, B.A. Chen et al. · Fertility and Sterility
Open access |
Sep 2018 |
0 |
| 31 |
Selected efficacy and bleeding/spotting outcomes from the secure trial: a phase 3 study of AG200-15, an investigational weekly transdermal contraceptive patch
A. Nelson, Andrew M. Kaunitz, Robin Kroll et al. · Fertility and Sterility
Open access |
Sep 2017 |
0 |
| 32 |
Results From the SECURE Trial, a Phase 3 Study of the AG200-15 Investigational Transdermal Contraceptive Patch [22A]
Elizabeth I. O. Garner, Joseph Chiodo · Obstetrics and Gynecology
|
May 2017 |
0 |
| 33 |
Perspectives on Clinical Therapeutics: a review of the past ten years and a look forward to the next decade.
G E Farrar · PubMed
|
1988 |
0 |
| 34 |
Evaluation of exposure to ethinyl estradiol (EE) with a low dose combination transdermal contraceptive delivery system (AG200-15) compared to low-dose combination oral contraceptive
D.F. Archer, Frank Z. Stanczyk, Arkady Rubin et al. · Fertility and Sterility
Open access |
27 Aug 2010 |
0 |
| 35 |
Safety and tolerability of the agile patch, a contraceptive patch with low-dose ethinyl estradiol (EE) and levonorgestrel (LNG), vs. combination oral contraceptives (COCs) in obese vs. non-obese women
Andrew M. Kaunitz, David F. Archer, Marie L. Foegh · Fertility and Sterility
Open access |
25 Aug 2012 |
0 |